2. Hennekens CH, Buring JE, Sandercock P, et al: Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 1989; 80: 749-756

3. Hennekens CH, Buring JE: Aspirin and cardiovascular disease. Bull NY Acad Med 1989; 65: 57-68

4. Peto R, Gray R, Collins R, et al: Randomised trial of prophylactic daily aspirin in British male doctors. BMJ 1988; 296: 313-316

5. Steering Committee of the Physicians' Health Study Research Group: Preliminary report: findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1988; 318: 262-264

6. Steering Committee of the Physicians' Health Study Research Group: Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321: 129-135

7. Manson JE, Grobbee DE, Stampfer MJ, et al: Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med 1990; 89: 772-776

8. Manson JE, Stampfer MJ, Colditz GA, et al: A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991 266(4): 521-527

9. Sempos CT, Cooper RS: The Physicians' Health Study: aspirin for the primary prevention of myocardial infarction [C]. N Engl J Med 1988; 318: 924-925

10. Hennekens CH, Peto R, Hutcheson GB, et al: An overview of the British and American aspirin studies [C] N Engl J Med 1988; 318: 923-924.

11. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet treatment. Part 1: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106

12. Jonas S: The Physicians' Health Study: a neurologist's concern. Arch Neurol 1990; 47: 1352-1353

13. Canadian Task Force on the Periodic Health Examination: The periodic health examination, 1991 update: 6. Acetylsalicylic acid and the primary prevention of cardiovascular disease. Can Med Assoc J 1991; 145: 1091-1095